Conference
Limited stage nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): A subgroup analysis of the HD.6 clinical trial.
Authors
Monteith B; DiMaria EC; Crump M; Ames JB; Winter JN; Djurfeldt M; Shepherd LE; Meyer RM; Chen BE; Hay AE
Volume
36
Pagination
pp. 7535-7535
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.7535
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X